Lucid Diagnostics (LUCD) Total Liabilities (2020 - 2026)

Lucid Diagnostics' Total Liabilities history runs 7 years deep, the most recent figure standing at $30.1 million for Q1 2026.

• Quarterly Total Liabilities fell 21.2% year-over-year to $30.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.1 million (down 21.2% YoY) and the FY2025 annual result came in at $29.5 million, up 16.53% from the prior year.
• Total Liabilities was $30.1 million for Q1 2026 at Lucid Diagnostics, up from $29.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $38.2 million in Q1 2025 and bottomed at $9.2 million in Q2 2022.
• A 5-year average of $23.1 million and a median of $25.3 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities plunged 60.47% — and 2023, when it jumped 212.63%.
• Lucid Diagnostics' Total Liabilities stood at $9.5 million in 2022, then soared by 212.63% to $29.6 million in 2023, then fell by 14.39% to $25.3 million in 2024, then climbed by 16.53% to $29.5 million in 2025, then climbed by 1.94% to $30.1 million in 2026.
• Business Quant data shows LUCD's Total Liabilities at $30.1 million in Q1 2026, $29.5 million in Q4 2025, and $27.4 million in Q3 2025.